Picture of CARGO Therapeutics logo

CRGX — CARGO Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Cargo Therapeutics Inc Expected To Post A Loss Of 67 Cents A Share: Earnings Preview

CARGO Therapeutics Inc CRGX.OQ CRGX.O is expected to show no change in quarterly revenue when it reports  results  for the period ending June 30 2025

​LSEG's mean analyst estimate for CARGO Therapeutics Inc is for a loss of 67 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts had risen by about 4.4% in the last three months. ​

Wall Street's median 12-month price target for CARGO Therapeutics Inc is $5.50​, above​ its last closing price of $4.02. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.57-0.72-1.77Missed-144.1
Dec. 31 2025-0.94-0.96-0.95Beat1.2
Sep. 30 2024-1.10-1.13-0.88Beat22.2​
Jun. 30 2024-1.01-1.03-1.02Beat0.7
​​Mar. 31 2024-1.06-1.05-0.87Beat17.4
Dec. 31 2023-1.44-1.44-1.49Missed-3.2​
Sep. 30 2023-2.78-2.78-47.37Missed-1,601.9
This summary was machine generated May 10 at 00:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on CARGO Therapeutics

See all news